The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter prospective study on the efficacy and safety of denosumab in gastrointestinal cancer patients receiving short-term periodic steroid premedication for prevention of chemotherapy-induced nausea and vomiting: ESPRESSO-02/HGCSG1602.
 
Michio Nakamura
Honoraria - Chugai Pharma; Daiichi Sankyo
 
Masataka Yagisawa
No Relationships to Disclose
 
Kentaro Sawada
No Relationships to Disclose
 
Tetsuhito Muranaka
No Relationships to Disclose
 
Hiroshi Nakatsumi
No Relationships to Disclose
 
Yasuyuki Kawamoto
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda
 
Masayoshi Dazai
No Relationships to Disclose
 
Atsushi Ishiguro
Honoraria - Chugai Pharma; Merck Serono; Taiho Pharmaceutical
 
Yoshimitsu Kobayashi
No Relationships to Disclose
 
Susumu Sogabe
No Relationships to Disclose
 
Takuto Miyagishima
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Miki Tateyama
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Kota Ono
No Relationships to Disclose
 
Yuh Sakata
Honoraria - Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Daiichi Sankyo; Otsuka; Taiho Pharmaceutical
 
Yoshito Komatsu
Speakers' Bureau - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Taiho Pharmaceutical; Takeda
Research Funding - AstraZeneca Japan (Inst); Chugai Pharma (Inst); MSD Oncology (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)